This job has expired

You will need to login before you can apply for a job.

2023 Co-Op, Immune Therapeutics Discovery

Moderna, Inc.
Cambridge, MA
Start date
Mar 23, 2023

View more

Job Details

The Role:

Modernas Immune Therapeutics Discovery (ITD) department is seeking a talented and motivated Co-op to join our team in support of developing new mRNA-based therapies. This is an exciting opportunity to help develop first-in-class therapeutics for patients in need, with lots of room for learning and growth. The Co-op will work on an individual project that is important to Modernas Immune Therapeutics Discovery mission with support from an experienced mentor who will provide guidance on projects and career. Applicants should be great team members, excellent communicators, with solid organizational skills. Our ideal candidate will be highly motivated and adaptable with a strong work ethic.

Our summer/fall co-op program is from July 17-December 15, 2023. All applicants must be available for the entire duration of the program.

Heres What Youll Do:

  • Help develop, optimize and validate cell-based assays to evaluate various mRNA therapeutics

  • Collaborate with internal teams on initial testing of mRNAs. Collect, archive, organize and analyze samples, including those from in vivo studies

  • Deliver reproducible and impactful results that meet deadlines

  • Execute and troubleshoot standard protocols, adapt new protocols into practice independently, and query literature to incorporate additional assays as needed

  • Independently execute experiments, faithfully documenting scientific work

  • Analyze, interpret and present data

  • Contribute to reports, regulatory submissions and presentations

Heres What Youll Bring to the Table (Preferred Qualifications):

  • Currently enrolled in undergraduate or graduate program with a focus on Biology, Biochemistry, Chemistry, Immunology, Cell Biology, Molecular Biology, or other related Life Science field

  • Fundamental knowledge and experience with wet lab techniques, including but not limited to tissue and cell culture

  • Candidates with strong knowledge/ experience in at least one of the following areas are strongly encouraged to apply:

    • Cell-based assays (e.g. transfection, transduction, viability, etc.)

    • Flow cytometry

    • Protein quantification techniques (e.g. Western, ELISA, MSD, Mass Spectrometry, Luminex-based assays)

    • RNA Purification, qPCR, other Molecular Biology techniques

    • Computational Science and/ or Bioinformatics

  • Capability to anticipate and recognize potential issues within experimental designs and effectively communicate alternatives

  • Candidate will embrace our core values. You will be curious in exploring new options for assay development and data presentation, bold in proposing creative experimental designs and ideas. You will work collaboratively with multifunctional teams and will be relentless in pursuing successful outcomes.

Moderna is pleased to provide you with an innovative suite of benefits, including:

  • Free premium access to meditation and mindfulness classes
  • Free parking or subsidized commuter passes
  • Generous paid time off, including:
    Vacation, sick time and holidays
    Volunteer time to participate within your community
    Discretionary year-end shutdown
  • Location-specific perks and extras!

Candidates should be aware that Moderna currently maintains a policy requiring all US-based employees to be fully vaccinated against COVID-19 and receive a booster shot once eligible. Newly hired employees must be vaccinated and boosted prior to their employment start date. Moderna is an equal opportunity employer and will provide a reasonable accommodation to those unable to be vaccinated or receive a booster where it is not an undue hardship to the company to do so as provided under federal, state, and local law.

About Moderna

In over 10 years since its inception, Moderna has transformed from a research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for rapid clinical and commercial production at scale. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna's capabilities have come together to allow the authorized use and approval of one of the earliest and most effective vaccines against the COVID-19 pandemic.

Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and autoimmune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past seven years. To learn more, visit

Moderna is a smoke-free, alcohol-free and drug-free work environment.

Moderna is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a persons race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law. Moderna will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.



Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. Moderna’s platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing the Company the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and cardiovascular diseases, independently and with strategic collaborators.

mRNA is now a turning point in the history of science, medicine, technology, even humankind itself. With this breakthrough discovery, many of the world’s biggest and most challenging medical problems are no longer a question of “how?” but merely a question of “when?”

Come with us as we pursue the uncharted reaches of possibility and make your mark on the future of medicine.


Stock Symbol:


Stock Exchange:



Facebook  Instagram  Twitter


Find Us
200 Technology Square
Cambridge, MA

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert